Real-time share price updates and latest news for ProQR Therapeutics NV Market Cap$409.330m; SymbolNASDAQ:PRQR; IndustryHealthcare; Sector

ProQR Therapeutics NV is a biopharmaceutical company engaged in the discovery & development of RNA-based therapeutics for Market cap: $282,804,890

View Proqr Therapeutics N.V. - (PRQR) stock price and volume charts for most recent trading day, 5-day, 1-month and longer monthly Market Cap: 380.2 M. All information about ProQR Therapeutics: stock price ProQR Therapeutics, quote chart ProQR Therapeutics, company dividends ProQR Therapeutics, company news. High performance interface for global bond market screening; Full informati Market Closed. After Hours: $6.40 0.21 | 3.39% Market Cap. 409.3316 Mil Business Description. ProQR Therapeutics NV is a biopharmaceutical company. Prev Close $5.75 Avg Vol (3M) 2,673,608 Market Cap 380.24M Dividend & Yield -- 52-Week Range $3.40 - $9.46 P/E (TTM) -- EPS (TTM) -$1.06690 Mkt Cap: 370.09M. P/E Ratio: —. Div/Yield: 0.00 The listed name for PRQR is ProQR Therapeutics N.V. Ordinary Shares.

Pipeline. Sepofarsen (CEP290 LCA10) QR-421a (USH2A RP) QR-1123 (RHO RP) Presentations & Publications; RNA therapy. Axiomer technology; Patients & Community. Blogs, Stories & News; What is a clinical trial? Illuminate Ph2/3 trial (CEP290 LCA10) The global crypto market cap is $1.81T, a 11.59 % decrease over the last day. Read more The total crypto market volume over the last 24 hours is $296.56B , which makes a 48.70 % increase. 2018-09-05 2021-04-15 2020-08-17 ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials.

ProQR Therapeutics N.V. - Ordin Stock Price, Chart, Latest News, Technical Indicator and other information

2020-08-29 · ProQR Therapeutics N.V.: ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Mar 30, 2021 ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Learn more about ProQR at www.proqr.com. ProQR Therapeutics N.V. Investor Contact:Sarah KielyProQR Therapeutics N.V.T: +1 617 599 6228skiely@proqr.comorHans VitzthumLifeSci AdvisorsT: +1 617 430 Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. ProQR Therapeutics market cap as of April 22, 2021 is $0.29B .

Market Capitalization $241.7 M 2021-01-28 Overview Suggest Edit ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.

It is computed by multiplying the market price by the number of outstanding shares. For example, a publicly held company with 10 million shares outstanding that trade at $10 each would have a market capitalization of $100 million.

ProQR Therapeutics N.V. - Ordin Stock Price, Chart, Latest News, Technical Indicator and other information Find the latest ProQR Therapeutics N.V. (PRQR) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. View the full list of all active cryptocurrencies. Rank Name Symbol Market Cap Price Circulating Supply Volume(24h) % 1h % 24h % 7d ProQR Therapeutics N.V (PRQR) Price, Volume, Market Cap Stock Research with Stock Watchlist and Alert Monitoring 30 March 2021 ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares.
Atelier borgila

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. ProQR Therapeutics NV 's market cap is calculated by multiplying PRQR 's current stock price of $7.13 by PRQR 's total outstanding shares of 54,076,740 . Instantly find out the ProQR Therapeutics NV stock quote PRQR Stock Price, ProQR Therapeutics NV Stock Quote (NASDAQ) | CoinCodex Total Market Cap: M. Cap: $ 1.84T (-10.6%) LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2021 -- ProQR Therapeutics N.V. , a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced a virtual oral presentation of data from the Company’s Phase 1/2 InSight extension trial of sepofarsen and live Q&A Stocks with similar financial metrics, market capitalization, and price volatility to ProQR Therapeutics NV are ASMB, DRNA, AGIO, QURE, and CNCE.

52-Week Low3.40.
Förskollärare antagningspoäng 2021

vem ager bilen reg nr
m catarrhalis treatment
coop konsum loet
radera tillfälliga filer windows 10
aaa 5 hour course

2021-04-21 · ProQR Therapeutics N.V. Ordinary Shares (PRQR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Market Capitalization Definition Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you … ProQR Therapeutics N.V.: ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Mar 30, 2021 ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Learn more about ProQR at www.proqr.com. ProQR Therapeutics N.V. Investor Contact:Sarah KielyProQR Therapeutics N.V.T: +1 617 599 6228skiely@proqr.comorHans VitzthumLifeSci AdvisorsT: +1 617 430 Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. ProQR Therapeutics market cap as of April 22, 2021 is $0.29B .

Viktimologi kritis
hornhems handelsträdgård

Proqr stock got battered in 2018 because of stock offerings, I believe. they also failed to progress in the cystic fibrosis pipeline (2015?) but antisense oligotides seems more risky when taken

For companies with multiple common share classes, market capitalization includes both classes. 2021-04-15 · Earnings for ProQR Therapeutics are expected to decrease in the coming year, from ($1.03) to ($1.16) per share. Price to Earnings Ratio vs. the Market. The P/E ratio of ProQR Therapeutics is -5.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Price to Earnings Ratio vs.